loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Drug Master Files (DMF) for 30402 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Dr. Reddy's Laboratories

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    Key Products KEY PRODUCTS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Aspen API. More than just an API.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Dr. Reddy's Laboratories (1)

    filter

    01 CARFILZOMIB (1)

    filter

    01 India (1)

    filter

    01 Active (1)

    filter

    01 Complete (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    DR REDDYS LABORATORIES LTD

    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    CARFILZOMIB

    PDF Supplier PDF
    URL Supplier Web Content
    Other DMF BR
    30402
    Active
    2016-03-29
    Complete
    2016-07-06
    2016-05-04
    II
    Dr Reddy Company Banner

    CPhI Japan

    Booth #5N-12

    envelop Contact Supplier

    Looking for Drug Master Files (DMF) for 30402 of Dr Reddys Laboratories Ltd

    Looking for Drug Master Files (DMF) for 30402 of Dr Reddys Laboratories Ltd 1

    20

    Dr Reddys Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    One of their notable products is CARFILZOMIB, with a corresponding US DMF Number 30402.

    Remarkably, this DMF maintains an Active status since its submission on March 29, 2016, highlighting commitment to regulatory compliance.

    Their GDUFA DMF Review was successfully complete, with a review date of July 06, 2016, and payment made on May 04, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II

    Post Enquiry
    POST ENQUIRY